• ONX-0914 (PR-957): Immune–Neural Assay Logic

  2026-08-30

  ONX-0914 (PR-957) is a selective LMP7 inhibitor for mechanistic studies of cytokine production and autoimmune inflammation. This article connects immunoproteasome pharmacology with rigorous assay logic from cortical synaptic research, helping investigators distinguish target engagement from downstream phenotype.

• H2O2, STOP1, and Aluminum Resistance in Arabidopsis

  2026-08-29

  This study identifies hydrogen peroxide as an active negative regulator of aluminum resistance rather than merely a byproduct of stress. It links mitochondrial dysfunction, cysteine oxidation, F-box-mediated degradation, and thioredoxin-dependent repair to the control of the transcription factor STOP1, providing a mechanistic framework for redox regulation of plant stress responses.

• Baicalein Assay Workflows for Cancer Research

  2026-08-28

  Baicalein supports practical studies of 12-LOX activity, cancer cell proliferation inhibition, apoptosis, and inflammatory signaling. This guide converts its solubility and stability profile into reproducible workflows and uses a recent neurotoxicity study to sharpen combination-assay design without overstating evidence.

• Pretomanid Targets Terminal Oxidases in TB

  2026-08-28

  The reference study identifies the cytochrome bcc:aa3 and cytochrome bd terminal oxidases as coordinated respiratory vulnerabilities exposed by pretomanid in Mycobacterium tuberculosis. Its combination data support rational regimens pairing pretomanid with Q203 and ND-011992 to improve killing of replicating and antibiotic-tolerant bacilli while limiting resistance emergence.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-27

  FITC-Concanavalin A (ConA) Conjugate, SKU K4413, provides direct fluorescent detection of α-D-glucose and α-D-mannose moieties on cell-surface glycoproteins and glycolipids. It is intended for carbohydrate-focused immunofluorescence, microscopy, flow cytometry, and glycobiology workflows, not for non-carbohydrate assays or target-specific molecular identification.

• ARCA EGFP mRNA: From Signal to Translation Strategy

  2026-08-27

  A thought-leadership guide to using ARCA EGFP mRNA as more than a routine reporter: a mechanistically informed benchmark for mRNA delivery, translation, formulation optimization, and translational decision-making.

• 17-AAG (Tanespimycin) Cancer Research Workflows

  2026-08-26

  17-AAG (Tanespimycin) enables mechanism-led studies of HSP90 client-protein loss, oncogenic pathway collapse, and cancer-cell death. This practical guide connects concentration-response assays with protein kinetics, model selection, and a cautious assay-design lesson from recent NINJ1–norovirus research.

• Verapamil in Hypoxia-Inflammation Assays

  2026-08-26

  Verapamil ((±)-Verapamil) helps researchers probe how prolonged enzyme-induced hypoxia connects oxidative stress, TXNIP signaling, and NLRP3-associated caspase-1 activity in urothelial cells. This guide translates the reference findings into formulation, assay-design, controls, and troubleshooting decisions while distinguishing validated observations from practical pilot recommendations.

• Mitomycin C: A DNA-Damage Lens on Tumor Invasion

  2026-08-25

  Mitomycin C is an antitumor antibiotic that can do more than suppress proliferation: it can serve as a controlled stress perturbation for studying invasion, EMT, and apoptosis. This article connects its DNA replication inhibition profile with BAF53a-associated glioma biology while separating validated evidence from testable hypotheses.

• HBsAg Hijacks TBK1 to Suppress IFN and Induce Autophagy

  2026-08-25

  The reference study identifies a mechanism in which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent interferon production and toward p62-associated autophagy. By combining molecular interaction studies, pharmacological perturbation, animal models, and human liver samples, the work links incomplete autophagy with HBV persistence and provides a framework for studying innate immune response modulation.

• Diminazene Aceturate: A Causal Assay Guide

  2026-08-24

  Diminazene Aceturate supports both trypanosome parasite research and ACE2 activation research, but its effects require careful biological separation. This guide presents a mechanism-first framework for connecting antiparasitic activity with mitochondrial biogenesis findings without overinterpreting pharmacological data.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-24

  Oh and colleagues developed a scalable human iPSC-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based criteria, providing a human platform for studying latency mechanisms and candidate interventions.

• HyperScript First-Strand cDNA Synthesis Kit Workflow

  2026-08-23

  Build reliable gene-expression assays from total RNA, poly(A)+ RNA, or difficult structured templates with flexible primer selection and thermally robust reverse transcription. This workflow connects the HyperScript First-Strand cDNA Synthesis Kit to comparative plant transcriptomics, low-copy targets, PCR amplification, and qPCR reaction optimization.

• Clasto-Lactacystin β-lactone: Proteasome Workflows

  2026-08-22

  Clasto-Lactacystin β-lactone provides a cell-permeable, irreversible way to test whether protein stability and proteasome activity control a phenotype. This practical guide connects proteasome inhibition assays with viral RIPK3 degradation, necroptosis, cancer research, and disease-model workflows.

• Medroxyprogesterone Acetate: A Mechanism-First Guide

  2026-08-21

  Explore how Medroxyprogesterone acetate and MPA can be interpreted across renal, reproductive, and neurobiological models. This mechanism-first guide connects receptor biology, assay design, and recent endometrial senescence research to improve experimental decisions.

8503 records 1/567 page Next 12345 下5页 Last page